Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

<p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Maria Lozano-Rabella (15056515) (author)
Andere auteurs:	Andrea Garcia-Garijo (15056518) (author), Jara Palomero (15056521) (author), Anna Yuste-Estevanez (15056524) (author), Florian Erhard (15056527) (author), Roc Farriol-Duran (15056530) (author), Juan Martín-Liberal (15056533) (author), Maria Ochoa-de-Olza (15056536) (author), Ignacio Matos (15056539) (author), Jared J. Gartner (15046103) (author), Michael Ghosh (15056542) (author), Francesc Canals (15056545) (author), August Vidal (15056548) (author), Josep Maria Piulats (15056551) (author), Xavier Matías-Guiu (15056554) (author), Irene Brana (15056557) (author), Eva Muñoz-Couselo (14957498) (author), Elena Garralda (15039090) (author), Andreas Schlosser (15056560) (author), Alena Gros (15056563) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items